Brouwer

TERRAVET LA PLUS is indicated for the control and treatment of diseases and infectious processes caused by oxytetracycline-susceptible microorganisms associated with the potent antipyretic, analgesic and anti-inflammatory effect of diclofenac. This association makes TERRAVET LA PLUS a particularly useful product to treat infections that occur with hyperthermia, pain or acute inflammatory processes.

Cattle: for the treatment of diseases such as pneumonia, bronchopneumonia, actinobacillosis, actinomycosis, anaplasmosis (sadness), symptomatic anthrax, bacterial enteritis, leptospirosis, septicemic mastitis, umbilical and joint infections, metritis, foot rot, pododermatitis, keratoconjunctivitis and other infections caused by oxytetracycline-susceptible microorganisms.

Sheep: for the treatment of pneumonia, bronchopneumonia, bacterial enteritis, symptomatic anthrax, foot rot, puerperal infections and other infections caused by oxytetracycline-susceptible microorganisms.

Swine: for the treatment of pneumonia, colibacillosis of piglets, atrophic rhinitis, bacterial gastroenteritis, puerperal infections, leptospirosis, botulism, mastitis, metritis and agalactia (MMA) and other infections caused by oxytetracycline-susceptible microorganisms.

Oxytetracycline is effective against Gram positive, Gram negative, Mycoplasma, Chlamydia, Rickettsiae, and Protozoan parasites of the following genera and species: Corynebacterium spp, Erysipelothrix rhusiopathiae, Listeria monocytogenes, Streptococcus spp, Actinobacilus spp, Bordetella spp, Brucella spp, Francisella tularensis, Haemophilus spp, Pasteurella spp, Mannheimia spp, Yersinia spp, Campylobacter spp, Borrelia spp, Leptospira spp, Actinomyces spp, Fusobacterium spp, Micoplasma spp, Chlamydia spp, Rickettsia spp and Anaplasma spp.